The iStent inject was safe and effective for treating multiple types of primary open-angle glaucoma individually and in conjunction with cataract surgery, according to data published in Journal of ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — The majority of patients who underwent laser trabeculoplasty or iStent implantation saw no ...
Multiple 5-, 6-, 7- and 8-Year Real-World Studies Published, Demonstrating Leading Efficacy & Safety Across the Entire Glaucoma Disease Spectrum SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos ...
(RTTNews) - Glaukos Corp. (GKOS) has submitted a supplemental pre-market approval application to the FDA for the iStent infinite Trabecular Micro-Bypass System. The iStent infinite is an ...
Matthew Traynor, MD, successfully completed iStent inject cases at Idaho Falls, Idaho-based Grand Teton Surgery Center, according to Glaukos Corp. Senior Regional Business Manager Jennifer Lee. Three ...
Glaukos Corporation GKOS recently submitted a supplemental pre-market approval (PMA) application to the FDA with respect to its iStent infinite Trabecular Micro-Bypass System. It is worth mentioning ...
San Clemente-based Glaukos Corp. anticipates strong revenue growth next year for its iStent products, based on a guarantee of reimbursement on procedures that use its iStent implant. Glaukos expects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback